SCHEMBL23375710

SCHEMBL23375710

COc1nc(Cl)ccc1N=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MERTK Q12866 1/20 0.40
TDP2 O95551 1/20 0.39
NSD2 O96028 1/20 0.39
ALDH1A1 P00352 2/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
CCNA1 P78396 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CCR4 P51679 7/20 0.31
CD274 Q9NZQ7 3/20 0.31
PDCD1 Q15116 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27177131 0.77 CCNA2 (0.34) CCNA2CDK2CCNA1CCR4POLB
SCHEMBL12892475 0.74 CHRNB2 (0.33) TDP2NSD2
SCHEMBL19407671 0.73 CRHBP (0.59) MERTKTDP2NSD2ALDH1A1GAA
SCHEMBL10071721 0.73 CYP3A4 (0.32) TDP2NSD2CRHBPCRHR2
SCHEMBL30503540 0.73 CRHBP (0.59) MERTKTDP2NSD2ALDH1A1GAA
SCHEMBL15195554 0.71 CRHBP (0.42) MERTKTDP2NSD2ALDH1A1GAA
SCHEMBL19237079 0.71 PDCD1LG2 (0.44) MERTKTDP2NSD2ALDH1A1GAA
SCHEMBL29361411 0.70 NNMT (0.49) MERTKALDH1A1HPGDSMN1; SMN2CDK2
SCHEMBL2527039 0.70 NNMT (0.49) MERTKALDH1A1HPGDSMN1; SMN2CDK2
SCHEMBL16234979 0.69 CRHBP (0.41) MERTKTDP2NSD2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210147453-A1 DIMETHYLPHOSPHINE OXIDE COMPOUND Guizhou Inochini Technology Co., Ltd (CN) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147453-A1 DIMETHYLPHOSPHINE OXIDE COMPOUND LRRK2, PDPK1, PARK7 MERTK 1344/4885TDP2 459/4885NSD2 1787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.